OMX Nordic 40
2.654,85
PKT
-17,49
PKT
-0,65
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 10:51 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 08:26 | Volvo (B) Overweight | JP Morgan Chase & Co. | |
| 17.06.26 | Volvo (B) Hold | Deutsche Bank AG | |
| 17.06.26 | Novo Nordisk Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 16.06.26 | Volvo (B) Buy | UBS AG | |
| 16.06.26 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 16.06.26 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 15.06.26 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 12.06.26 | Nokia Overweight | JP Morgan Chase & Co. | |
| 11.06.26 | AstraZeneca Sell | Deutsche Bank AG | |
| 11.06.26 | Volvo (B) Hold | Deutsche Bank AG | |
| 11.06.26 | Volvo (B) Market-Perform | Bernstein Research | |
| 11.06.26 | Volvo (B) Sector Perform | RBC Capital Markets | |
| 11.06.26 | Volvo (B) Buy | UBS AG | |
| 10.06.26 | Volvo (B) Overweight | JP Morgan Chase & Co. | |
| 09.06.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 09.06.26 | Novo Nordisk Hold | Deutsche Bank AG | |
| 09.06.26 | AstraZeneca Sell | Deutsche Bank AG | |
| 09.06.26 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 09.06.26 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 08.06.26 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 08.06.26 | Volvo (B) Overweight | JP Morgan Chase & Co. | |
| 05.06.26 | Volvo (B) Sector Perform | RBC Capital Markets | |
| 05.06.26 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 04.06.26 | Novo Nordisk Neutral | Goldman Sachs Group Inc. | |
| 03.06.26 | Volvo (B) Market-Perform | Bernstein Research | |
| 02.06.26 | Volvo (B) Market-Perform | Bernstein Research | |
| 02.06.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 01.06.26 | AstraZeneca Overweight | Barclays Capital | |
| 01.06.26 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 01.06.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 29.05.26 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 29.05.26 | Hennes Mauritz (H M, H&M) Hold | Jefferies & Company Inc. | |
| 28.05.26 | AstraZeneca Sell | Deutsche Bank AG | |
| 28.05.26 | Novo Nordisk Hold | Deutsche Bank AG | |
| 28.05.26 | Hennes Mauritz (H M, H&M) Neutral | UBS AG | |
| 27.05.26 | Volvo (B) Buy | Goldman Sachs Group Inc. | |
| 21.05.26 | Hennes Mauritz (H M, H&M) Underweight | Barclays Capital | |
| 21.05.26 | AstraZeneca Sell | Deutsche Bank AG | |
| 20.05.26 | Nokia Overweight | JP Morgan Chase & Co. |